UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer

Cell stem cell, 2015-09, Vol.17 (3), p.260-271

2015

Volltextzugriff (PDF)

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.514-522

2017

Volltextzugriff (PDF)

The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling

Breast cancer research : BCR, 2023-11, Vol.25 (1), p.144-144, Article 144

2023

Volltextzugriff (PDF)

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells

Cell systems, 2017-09, Vol.5 (3), p.295-304.e4

2017

Volltextzugriff (PDF)

Tunable Thermal-Sensitive Polymer-Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells

Advanced materials (Weinheim), 2016-06, Vol.28 (24), p.4891-4897

2016

Volltextzugriff (PDF)

Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone

Science translational medicine, 2016-05, Vol.8 (340), p.340ra73

2016

Volltextzugriff (PDF)

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

Annals of surgical oncology, 2019-05, Vol.26 (5), p.1214-1224

2019

Volltextzugriff (PDF)

Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review

Supportive care in cancer, 2022-10, Vol.30 (10), p.8349-8355

2022

Volltextzugriff (PDF)

Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis

Cell research, 2018-04, Vol.28 (4), p.391-392

2018

Volltextzugriff (PDF)

Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?

The cancer journal (Sudbury, Mass.), 2010-01, Vol.16 (1), p.23-32

2010

Volltextzugriff (PDF)

Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy

British journal of clinical pharmacology, 2020-05, Vol.86 (5), p.880-890

2020

Volltextzugriff (PDF)

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.707-714

2020

Volltextzugriff (PDF)

The stem cell niche in health and malignancy

Seminars in cancer biology, 2010-04, Vol.20 (2), p.107-115

2010

Volltextzugriff (PDF)

Patients carrying CYP2C83 have shorter systemic paclitaxel exposure

Pharmacogenomics, 2019-01, Vol.20 (2), p.95-104

2019

Volltextzugriff (PDF)

Identifying Barriers and Facilitators to Scalp Cooling Therapy Through a National Survey of the Awareness, Practice Patterns, and Attitudes of Oncologists

JCO oncology practice, 2022-02, Vol.18 (2), p.e225-e234

2022

Volltextzugriff (PDF)

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study

JCO precision oncology, 2024-02, Vol.8 (8), p.e2300513

2024

Volltextzugriff (PDF)

Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

Journal of clinical oncology, 2011-05, Vol.29 (13), p.1652-1654

2011

Volltextzugriff (PDF)

Triple Negative Breast Cancer in BRCA1 Mutation Carriers With a Complete Radiologic Response to Neoadjuvant Paclitaxel: A Case Report

Clinical breast cancer, 2015-04, Vol.15 (2), p.e155-e158

2015

Volltextzugriff (PDF)

Abstract 3307: Label-free high throughput microfluidic device for the isolation and single cell multiplex gene expression analysis of circulating tumor cells from breast cancer patients

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3307-3307

2016

Volltextzugriff (PDF)

Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells

Annals of surgical oncology, 2006-01, Vol.13 (1), p.125-133

2006

Volltextzugriff (PDF)

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Clinical cancer research, 2018-08, Vol.24 (15), p.3602-3610

2018

Volltextzugriff (PDF)

Treatment of Pregnancy-Associated Breast Cancer

Current breast cancer reports, 2021-06, Vol.13 (2), p.81-86

2021

Volltextzugriff (PDF)

Abstract P2-05-05: RAD51 inhibition using CYT-0851, shows anti-cancer activity in cellular models of breast cancer and acts synergistically with PARP inhibitors

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-05-05

2020

Volltextzugriff (PDF)

Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with FGFR1 mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT173-CT173

2021

Volltextzugriff (PDF)

Characterizing Circulating Tumor Cells Isolated from Metastatic Breast Cancer Patients Using Graphene Oxide Based Microfluidic Assay

Advanced biosystems, 2019-02, Vol.3 (2), p.e1800278-n/a

2019

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells

Tunable Thermal-Sensitive Polymer-Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells

Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review

Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis

Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?

Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

The stem cell niche in health and malignancy

Patients carrying CYP2C83 have shorter systemic paclitaxel exposure

Identifying Barriers and Facilitators to Scalp Cooling Therapy Through a National Survey of the Awareness, Practice Patterns, and Attitudes of Oncologists

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study

Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

Triple Negative Breast Cancer in BRCA1 Mutation Carriers With a Complete Radiologic Response to Neoadjuvant Paclitaxel: A Case Report

Abstract 3307: Label-free high throughput microfluidic device for the isolation and single cell multiplex gene expression analysis of circulating tumor cells from breast cancer patients

Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Treatment of Pregnancy-Associated Breast Cancer

Abstract P2-05-05: RAD51 inhibition using CYT-0851, shows anti-cancer activity in cellular models of breast cancer and acts synergistically with PARP inhibitors

Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with FGFR1 mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Characterizing Circulating Tumor Cells Isolated from Metastatic Breast Cancer Patients Using Graphene Oxide Based Microfluidic Assay

Suchergebnisse filtern